drugset / Trial / NCT00668577

Dermatological Evaluation of Topic Compatibility - Dermacyd Breeze

NCT00668577

Phase 3 Completed 52 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to demonstrate the absence of irritation potential (primary dermal irritability and cumulated dermal irritability) and allergy (sensibilization) of the product Dermacyd Pocket BR.

Timeline

Start
2007-12
Primary completion
2008-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified

Indications

No indication recorded.